Rejoni, Inc is a dynamic player in the Biotechnology and Health Care sectors, founded in 2020 and headquartered in the United States. The company's mission is to develop innovative solutions designed to minimize the short and long-term risks associated with gynecological procedures. With a focus on women's health, Rejoni aims to empower women to achieve the life they desire both now and in the future.
Demonstrating impressive growth, Rejoni secured a $26.25M Series B investment on 07 December 2022. This funding round included notable investors such as Ascension Ventures, Delos Capital, Sparta Group, CHV, FemHealth Ventures, AMED Ventures, and Iyengar Capital Partners. This financial backing underscores significant confidence in the company's potential to innovate and scale within the Medical Devices industry.